ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma

NCT06904378 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: ONT01
DRUG: Gemcitabine
DRUG: Nab paclitaxel

Sponsor

Washington University School of Medicine

Collaborators

[object Object]